Enhancement of the antitumor activity of ionising radiation by nimotuzumab, a humanised monoclonal antibody to the epidermal growth factor receptor, in non-small cell lung cancer cell lines of differing epidermal growth factor receptor status. [electronic resource]
Producer: 20080422Description: 749-55 p. digitalISSN:- 0007-0920
- Animals
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Blotting, Western
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cell Membrane -- metabolism
- Colony-Forming Units Assay
- Combined Modality Therapy
- ErbB Receptors -- immunology
- Female
- Flow Cytometry
- Humans
- Lung Neoplasms -- drug therapy
- Mice
- Mice, Nude
- Phosphorylation -- drug effects
- Radiation, Ionizing
- Radiation-Sensitizing Agents -- therapeutic use
- Tumor Cells, Cultured -- drug effects
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.